Research article · 25 Jun 2026
CommentaryPublished 12 Dec 2022
Antiretroviral Treatment in Asymptomatic Early HIV
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Loss of CD4+ T cells signifies the immunological compromise brought on by the human immunodeficiency virus (HIV). As the quantity of these cells in peripheral blood (CD4+ count) decreases, the rates of HIV-related illnesses and fatalities rise. Antiretroviral medication is typically started later in asymptomatic patients with a CD4+ count over a predetermined threshold. The relevant threshold has evolved over time, and various guidelines continue to make varying suggestions. Patients with a CD4+ count of less than 500 cells per cubic millimetre have been enrolled in the majority of random studies that have evaluated the advantages and disadvantages. A CD4+ count of 200 or 250 cells per cubic millimetre has been used as the definition of "later" in several studies. Strong support for the start of antiretroviral medication in patients with a CD4+ count of 350 cells per cubic millimetre is shown by these results and observational studies
Subjects
Infectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in HIV: Current Research.
Perspective · 25 Apr 2025
Digital Age HIV Stigma and the Role of Online Communities
Short communication · 1 Apr 2025
Mental Health Inclusion in HIV Management toward Whole-Person Care
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalHIV: Current Research
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Emtithal Omar”
